A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons

Hippocampus

Volumn 22, Issue 2, 2012, Pages 209-221

  Edwards, Jeffrey G ^a,b   Gibson, Helen E ^a   Jensen, Tyron ^b   Nugent, Fereshteh ^a   Walther, Curtis ^b   Blickenstaff, Jacob ^b   Kauer, Julie A ^a  

^a BROWN UNIVERSITY   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Anandamide; Hippocampus; MGluR5; Plasticity; THC

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; ANANDAMIDE; CAPSAZEPINE; ENDOCANNABINOID; METABOTROPIC RECEPTOR 1; METHANANDAMIDE; VANILLOID RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DEPRESSION; EXCITATORY POSTSYNAPTIC POTENTIAL; INTERNEURON; NERVE CELL PLASTICITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; STRATUM RADIATUM; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; ARACHIDONIC ACIDS; CA1 REGION, HIPPOCAMPAL; ENDOCANNABINOIDS; EXCITATORY POSTSYNAPTIC POTENTIALS; INTERNEURONS; LONG-TERM SYNAPTIC DEPRESSION; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, METABOTROPIC GLUTAMATE; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTIC TRANSMISSION; TRPV CATION CHANNELS;

EID: 84856087132     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20884     Document Type: Article

References (76)

1. Al-Hayani A, Wease KN, Ross RA, Pertwee RG, Davies SN. 2001. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41: 1000-1005.
2. Ameri A. 1999. The effects of cannabinoids on the brain. Progress in Neurobiology 58: 315-348.
3. Ameri A, Wilhelm A, Simmet T. 1999. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126: 1831-1839.
4. Auclair N, Otani S, Soubrie P, Crepel F. 2000. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83: 3287-3293.
5. Bliss TVP, Lomo T. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232: 331-356.
6. Bolshakov V, Siegelbaum S. 1994. Postsynaptic induction and presynaptic expression of hippocampal long-term depression. Science 264: 1148-1152.
7. Breivogel CS, Griffin G, Di Marzo V, Martin BR. 2001. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60: 155-163.
8. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, Lory P. 2001. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20: 7033-7040.
9. Chevaleyre V, Castillo PE. 2003. Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability. Neuron 38: 461-472.
10. Cobb SR, Buhl EH, Halasy K, Paulsen O, Somogyi P. 1995. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378: 75-78.
11. Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR. 2000. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. J Neurochem 75: 2434-2444.
12. Di Marzo V, Bisogno T, De Petrocellis L. 2001. Anandamide: Some like it hot. Trends Pharmacol Sci 22: 346-349.
13. Doherty J, Dingledine R. 1998. Differential regulation of synaptic inputs to dentate Hilar border interneurons by metabotropic glutamate receptors. J Neurophysiol 79: 2903-2910.
14. Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt H-U, Zieglgansberger W, Lutz B, Rammes G. 2006. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 26: 5794-5799.
15. Dudek SM, Bear MF. 1992. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci USA 89: 4363-4367.
16. Faas GC, Adwanikar H, Gereau RWIV, Saggau P. 2002. Modulation of presynaptic calcium transients by metabotropic glutamate receptor activation: A differential role in acute depression of synaptic transmission and long-term depression. J Neurosci 22: 6885-6890.
17. Feinmark SJ, Begum R, Tsvetkov E, Goussakov I, Funk CD, Siegelbaum SA, Bolshakov VY. 2003. 12-Lipoxygenase metabolites of arachidonic acid mediate metabotropic glutamate receptor-dependent long-term depression at hippocampal CA3-CA1 synapses. J Neurosci 23: 11427-11435.
18. Fitzjohn SM, Palmer MJ, May JER, Neeson A, Morris SAC, Collingridge GL. 2001. A characterization of long-term depression induced by metabotropic glutamate receptor activation in the rat hippocampus in vitro. J Physiol 537: 421-430.
19. Gibson HE, Edwards JG, Page RS, Van Hook MJ, Kauer JA. 2008. TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons. Neuron 57: 746-759.
20. Gulyas Al, Toth K, McBain CJ, Freund TF. 1998. Stratum radiatum giant cells: A type of principal cell in the rat hippocampus. Euro J Neurosci 10: 3813-3822.
21. Hajos N, Freund TF. 2002a. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids 121: 73-82.
22. Hajos N, Freund TF. 2002b. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology 43: 503-510.
23. Hajos N, Ledent C, Freund TF. 2001. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106: 1-4.
24. Huang C-C, You J-L, Wu M-Y, Hsu K-S. 2004. Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI{middle dot}Rab5 complex: Potential role in (S)-3, 5-dihydroxyphenylglycine-induced long term depression. J Biol Chem 279: 12286-12292.
25. Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, Tognetto M, Petros TJ, Krey JF, Chu CJ, Miller JD, Davies SN, Geppetti P, Walker JM, Di Marzo V. 2002. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci USA 99: 8400-8405.
26. Huber KM, Kayser MS, Bear MF. 2000. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. Science 288: 1254-1256.
27. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19: 4544-4558.
28. Katona I, Urban GM, Wallace M, Ledent C, Jung K-M, Piomelli D, Mackie K, Freund TF. 2006. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
29. Kawamura Y, Fukaya M, Maejima T, Yoshida T, Miura E, Watanabe M, Ohno-Shosaku T, Kano M. 2006. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 26: 2991-3001.
30. Kelley BG, Thayer SA. 2004. Δ9-Tetrahydrocannabinol antagonizes endocannabinoid modulation of synaptic transmission between hippocampal neurons in culture. Neuropharmacology 46: 709-715.
31. Kim HI, Kim TH, Shin YK, Lee CS, Park M, Song J-H. 2005. Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. Brain Res 1062: 39-47.
32. Kofalvi A, Vizi ES, Ledent C, Sperlagh B. 2003. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur J Neurosci 18: 1973-1978.
33. Kreitzer AC, Carter AG, Regehr WG. 2002. Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. Neuron 34: 787-796.
34. Kullmann DM, Lamsa KP. 2007. Long-term synaptic plasticity in hippocampal interneurons. Nat Rev Neurosci 8: 687-699.
35. Lamsa K, Heeroma JH, Kullmann DM. 2005. Hebbian LTP in feed-forward inhibitory interneurons and the temporal fidelity of input discrimination. Nat Neurosci 8: 916-924.
36. Le Vasseur M, Ran I, Lacaille JC. 2008. Selective induction of metabotropic glutamate receptor 1- and metabotropic glutamate receptor 5-dependent chemical long-term potentiation at oriens/alveus interneuron synapses of mouse hippocampus. Neuroscience 151: 28-42.
37. Li H-B, Mao R-R, Zhang J-C, Yang Y, Cao J, Xu L. 2008. Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory. Biol Psychiatry 64: 286-292.
38. Liu J, Wang L, Harvey-White J, Osei-Hyiaman D, Razdan R, Gong Q, Chan AC, Zhou Z, Huang BX, Kim H-Y, Kunos G. 2006. A biosynthetic pathway for anandamide. Proc Natl Acad Sci USA 103: 13345-13350.
39. Maccarrone M, Rossi S, Bari M, De Chiara V, Fezza F, Musella A, Gasperi V, Prosperetti C, Bernardi G, Finazzi-Agro A, Cravatt BF, Centonze D. 2008. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11: 152-159.
40. Manahan-Vaughan D, Braunewell K-H. 2005. The metabotropic glutamate receptor, mGluR5, is a Key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb Cortex 15: 1703-1713.
41. Mannaioni G, Marino MJ, Valenti O, Traynelis SF, Conn PJ. 2001. Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function. J Neurosci 21: 5925-5934.
42. Marsch R, Foeller E, Rammes G, Bunck M, Kossl M, Holsboer F, Zieglgansberger W, Landgraf R, Lutz B, Wotjak CT. 2007. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci 27: 832-839.
43. McBain CJ, DiChiara TJ, Kauer JA. 1994. Activation of metabotropic glutamate receptors differentially affects two classes of hippocampal interneurons and potentiates excitatory synaptic transmission. J Neurosci 14: 4433-4445.
44. McMahon LL, Kauer JA. 1997. Hippocampal interneurons express a novel form of synaptic plasticity. Neuron 18: 295-305.
45. Meuth SG, Aller MI, Munsch T, Schuhmacher T, Seidenbecher T, Meuth P, Kleinschnitz C, Pape H-C, Wiendl H, Wisden W, Budde T. 2006. The contribution of twik-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. Mol Pharmacol 69: 1468-1476.
46. Mulkey RM, Malenka RC. 1992. Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9: 967-975.
47. Ohno-Shosaku T, Shosaku J, Tsubokawa H, Kano M. 2002. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur J Neurosci 15: 953-961.
48. Oliet SHR, Malenka RC, Nicoll RA. 1997. Two distinct forms of long-term depression coexist in CA1 hippocampal pyramidal cells. Neuron 18: 969-982.
49. Pelkey KA, McBain CJ. 2008. Target-cell-dependent plasticity within the mossy fibre-CA3 circuit reveals compartmentalized regulation of presynaptic function at divergent release sites. J Physiol 586: 1495-1502.
50. Pelkey KA, Lavezzari G, Racca C, Roche KW, McBain CJ. 2005. mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron 46: 89-102.
51. Perez Y, Morin F, Lacaille J-C. 2001. A hebbian form of long-term potentiation dependent on mGluR1a in hippocampal inhibitory interneurons. Proc Natl Acad Sci USA 98: 9401-9406.
52. Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. 2004. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: Evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 46: 115-125.
53. Placzek EA, Okamoto Y, Ueda N, Barker EL. 2008a. Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. J Neurochem 107: 987-1000.
54. Placzek EA, Okamoto Y, Ueda N, Barker EL. 2008b. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. Neuropharmacology 55: 1095-1104.
55. Poling JS, Rogawski MA, Salem N, Vicini S. 1996. Anandamide, an endogenous cannabinoid, inhibits shaker-related voltage-gated K+ channels. Neuropharmacology 35: 983-991.
56. Rae MG, Irving AJ. 2004. Both mGluR1 and mGluR5 mediate Ca2+ release and inward currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46: 1057-1069.
57. Rammes G, Palmer M, Eder M, Dodt H-U, Zieglgansberger W, Collingridge GL. 2003. Activation of mGlu receptors induces LTD without affecting postsynaptic sensitivity of CA1 neurons in rat hippocampal slices. J Physiol 546: 455-460.
58. Roberts LA, Ross HR, Connor M. 2008. Methanandamide activation of a novel current in mouse trigeminal ganglion sensory neurons in vitro. Neuropharmacology 54: 172-180.
59. Romano C, Sesma MA, McDonald CT, O'malley K, Pol ANvd, Olney JW. 1995. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol 355: 455-469.
60. Rouach N, Nicoll RA. 2003. Endocannabinoids contribute to short-term but not long-term mGluR-induced depression in the hippocampus. Eur J Neurosci 18: 1017-1020.
61. Schools GP, Kimelberg HK. 1999. mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats. J Neurosci Res 58: 533-543.
62. Servitja J-M, Masgrau R, Sarri E, Picatoste F. 1999. Group I metabotropic glutamate receptors mediate phospholipase D stimulation in rat cultured astrocytes. J Neurochem 72: 1441-1447.
63. Sik A, Penttonen M, Ylinen A, Buzsaki G. 1995. Hippocampal CA1 interneurons: An in vivo intracellular labeling study. J Neurosci 15: 6651-6665.
64. Snyder EM, Philpot BD, Huber KM, Dong X, Fallon JR, Bear MF. 2001. Internalization of ionotropic glutamate receptors in response to mGluR activation. Nat Neurosci 4: 1079-1085.
65. Straiker A, Mackie K. 2005. Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569: 501-517.
66. Takahashi KA, Castillo PE. 2006. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus. Neuroscience 139: 795-802.
67. Topolnik L, Azzi M, Morin F, Kougioumoutzakis A, Lacaille J-C. 2006. mGluR1/5 subtype-specific calcium signalling and induction of long-term potentiation in rat hippocampal oriens/alveus interneurones. J Physiol 575: 115-131.
68. Traub RD, Pais I, Bibbig A, LeBeau FEN, Buhl EH, Garner H, Monyer H, Whittington MA. 2005. Transient depression of excitatory synapses on interneurons contributes to epileptiform bursts during gamma oscillations in the mouse hippocampal slice. J Neurophysiol 94: 1225-1235.
69. Varma N, Carlson GC, Ledent C, Alger BE. 2001. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21: 188RC.
70. Volk LJ, Daly CA, Huber KM. 2006. Differential roles for group 1 mGluR subtypes in induction and expression of chemically induced hippocampal long-term depression. J Neurophysiol 95: 2427-2438.
71. Watabe AM, Carlisle HJ, O'Dell TJ. 2002. Postsynaptic induction and presynaptic expression of group 1 mGluR-dependent LTD in the hippocampal CA1 region. J Neurophysiol 87: 1395-1403.
72. Whittington MA, Traub RD. 2003. Interneuron diversity series: Inhibitory interneurons and network oscillations in vitro. Trends Neurosci 26: 676-682.
73. Wilson RI, Nicoll RA. 2001. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592.
74. Wilson RI, Nicoll RA. 2002. Endocannabinoid signaling in the brain. Science 296: 678-682.
75. Xiao M-Y, Zhou Q, Nicoll RA. 2001. Metabotropic glutamate receptor activation causes a rapid redistribution of AMPA receptors. Neuropharmacology 41: 664-671.
76. Zakharenko SS, Zablow L, Siegelbaum SA. 2002. Altered presynaptic vesicle release and cycling during mGluR-dependent LTD. Neuron 35: 1099-1110.